Donna Shiroma - Nov 30, 2023 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
General Counsel
Signature
/s/ Donna Shiroma
Stock symbol
RCEL
Transactions as of
Nov 30, 2023
Transactions value $
$13,309
Form type
4
Date filed
1/5/2024, 05:51 PM
Previous filing
Sep 8, 2023
Next filing
Jun 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award $13.3K +1.47K +3.48% $9.06 43.7K Nov 30, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +100K $0.00 100K Jan 3, 2024 Common Stock 100K $12.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase which began July 1, 2023 and ended November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period).
F2 Includes unvested RSUs
F3 These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date.